OTCMKTS:VIMGF Vimian Group AB (publ) (VIMGF) Stock Forecast, Price & News C$2.25 0.00 (0.00%) (As of 09/27/2023 ET) Add Compare Share Share Today's RangeC$2.25▼C$2.2550-Day RangeC$2.25▼C$3.3252-Week RangeC$2.25▼C$2.25VolumeN/AAverage Volume360 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Vimian Group AB (publ) (OTCMKTS:VIMGF) StockVimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.Read More VIMGF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIMGF Stock News HeadlinesJuly 19, 2023 | finance.yahoo.comNotice to attend Extraordinary General Meeting in Anoto Group AB (publ)July 19, 2023 | investing.comKarnov Group AB (KARNO)September 28, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.May 4, 2023 | finance.yahoo.comVimian's Interim Report for the First Quarter of 2023April 4, 2023 | msn.comBRIEF-Vimian Says Subsidiary Reaches Settlement Agreement Resolving Patent Litigation With Depuy SynthesMarch 20, 2023 | finance.yahoo.comVimian’s Interim Report for the Second Quarter of 2022March 20, 2023 | finance.yahoo.comVimian’s Interim Report for the Third Quarter of 2022See More Headlines Receive VIMGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vimian Group AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VIMGF CUSIPN/A CIKN/A Webvimian.com Phone46 7 36 26 88 86FaxN/AEmployees1,068Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Fredrik Ullman (Age 43)Interim Chief Exec. Officer Comp: $403.4kMr. Carl-Johan Zetterberg Boudrie (Age 45)Chief Financial Officer Ms. Maria Dahllof Tullberg (Age 42)Head of IR, Communications & Sustainability Mr. Carl-Johan Ehn (Age 49)Gen. Counsel Mr. Magnus Kjellberg (Age 50)Chief Exec. Officer of Nextmune Mr. Martin BengtsonHead of M&AMr. Stefano Santarelli (Age 42)Chief Exec. Officer of Indical Bioscience Mr. Guy C. Sporri (Age 43)Co-Chief Exec. Officer of Movora Mr. Alireza Tajbakhsh (Age 40)Head & CEO of VetFamily Colleen Flesher (Age 47)Co-Chief Exec. Officer of Movora More ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors VIMGF Stock - Frequently Asked Questions Should I buy or sell Vimian Group AB (publ) stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vimian Group AB (publ) in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VIMGF shares. View VIMGF analyst ratings or view top-rated stocks. How have VIMGF shares performed in 2023? Vimian Group AB (publ)'s stock was trading at C$3.20 at the start of the year. Since then, VIMGF shares have decreased by 29.7% and is now trading at C$2.25. View the best growth stocks for 2023 here. What is Vimian Group AB (publ)'s stock symbol? Vimian Group AB (publ) trades on the OTCMKTS under the ticker symbol "VIMGF." How do I buy shares of Vimian Group AB (publ)? Shares of VIMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Vimian Group AB (publ)'s stock price today? One share of VIMGF stock can currently be purchased for approximately C$2.25. How many employees does Vimian Group AB (publ) have? The company employs 1,068 workers across the globe. How can I contact Vimian Group AB (publ)? Vimian Group AB (publ)'s mailing address is Riddargatan 19, Stockholm 11457, Sweden, . The official website for the company is vimian.com. The company can be reached via phone at 46 7 36 26 88 86. This page (OTCMKTS:VIMGF) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vimian Group AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.